Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds

Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds

May 17, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Beam Therapeutics announced today that it has launched with $87 million in Series A funding to develop precision genetic medicines that make edits to individual base pairs in the genome.

The funding round was led by F-Prime Capital Partners and ARCH Venture Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Finds a Whole Bunch

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Away From the Field

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

PNAS Studies Look at Bacterial Detection Probes, Cholera Culprit Evolution in Environment, More

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

In a Different Lab

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

What's Popular?

In Business News

  1. Color Gears Up to Enter COVID-19 Testing Space

  2. Cue Health Awarded $13M BARDA Contract for POC Coronavirus Test

  3. Luminex Receives Second BARDA Contract for $642K to Develop Rapid SARS-CoV-2 Test

  4. Thermo Fisher Scientific Prices €1.2B Senior Notes Offering

  5. MedGenome Raises $55M From Investors

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.